A different perspective on the dilemma of durotomy or duraplasty in Chiari type 1 malformation surgery

Br J Neurosurg. 2023 Oct;37(5):1112-1116. doi: 10.1080/02688697.2022.2106353. Epub 2022 Aug 4.

Abstract

Purpose: Symptomatic Chiari type 1 malformation (CIM) patients may elect to be treated; however, choosing the optimum surgical method remains problematic: posterior fossa decompression with duraplasty (PFDD) or without duraplasty (PFD). Many studies have compared these surgical methods from several perspectives. We looked at soft tissue density (STD) at the foramen magnum to add another perspective to the comparison of PFD with PFDD.

Materials and methods: Eighty-six patients who underwent surgery in our clinic were included in the study. We examined preoperative and postoperative MR images taken in the 1st year. We obtained the foramen magnum area (FMA) and soft tissue at the level of the foramen magnum. The STD within the foramen magnum was calculated as the percentage ratio of soft tissue area (STA) to FMA. Anteroposterior diameters of the syrinx cavities in sagittal T2 sections were measured preoperatively and at 1-year postoperatively. Measurements were double-blind and were performed by the neurosurgeon and by the neuroradiologist.

Results: There was no statistically significant difference between the postoperative FMA increases, STA changes, STD changes in patients who underwent PFD and PFDD. In this study, there was no statistically significant difference between PFD and PFDD in terms of syrinx changes.

Conclusions: The medium-term anatomical outcome following craniovertebral decompression for CIM, is no different whether performed PFD or PFDD.

Keywords: Chiari Type 1 Malformation; duraplasty; durotomy.

MeSH terms

  • Arnold-Chiari Malformation* / diagnostic imaging
  • Arnold-Chiari Malformation* / surgery
  • Decompression, Surgical* / methods
  • Double-Blind Method
  • Dura Mater / surgery
  • Foramen Magnum / surgery
  • Humans
  • Retrospective Studies
  • Treatment Outcome